- Original article
- Open Access
The frequency of efflux pump genes expression in Acinetobacter baumannii isolates from pulmonary secretions
AMB Express volume 12, Article number: 103 (2022)
Acinetobacter baumannii is an important opportunistic pathogen, and the cause of nosocomial infections worldwide in recent decades. Efflux pumps are considered as the important causes of multidrug resistance of A. baumannii. The aim of this study was to determine the frequency of efflux pump genes, and evaluate the antibiotic effect of Tigecycline on the expression of adeB gene in isolates of multidrug-resistant. A. baumannii. 70 isolates of A. baumannii were collected and confirmed by biochemical and molecular tests. Antibiotic resistance (Ciprofloxacin, Trimethoprim-sulfamethoxazole, and Tigecycline) was performed based on the minimum inhibitory concentration (MIC) method. Then, the effect of Carbonyl cyanide m-chlorophenyl hydrazone inhibitor (CCCP) on isolates was investigated and the frequency of adeB, adeG, adeJ and abeM genes were examined by PCR for isolates with reduced in MIC titer. Also, the antibiotic effect of Tigecycline on adeB gene expression in A. baumannii isolates was analyzed by Real-Time PCR. The antibiotic resistance for Ciprofloxacin, Trimethoprim-sulfamethoxazole, and Tigecycline was 97.1%, 95.8% and 37.2%, respectively. Following CCCP inhibitor use, the MIC titer had a decrease in MIC titer containing CCCP inhibitor was 64.3% for Ciprofloxacin, 51.5% for Trimethoprim-sulfamethoxazole and 50% for Tigecycline. The frequencies of genes associated with adeB, adeG, adeJ and abeM efflux pump were 100%, 92.8%, 86% and 98.5%, respectively. Real-Time PCR results showed a correlation between the antibiotic effects of Tigecycline on adeB gene expression. The antibiotic resistance of the isolates was relatively high. The isolates were resistant to Ciprofloxacin and Trimethoprim-sulfamethoxazole antibiotics, while more sensitive to Tigecycline. Also, efflux pump genes, which are the antibiotic resistance factors of A. baumannii, are frequently high in the isolates but it seems that isolates use other effluxe pumps than RND family to exit tigecycline.
The frequencies of genes associated with adeB, adeG, adeJ and abeM efflux pump were 100%, 92.8%, 86% and 98.5%, respectively.
Real-Time PCR results showed a correlation between the antibiotic effects of Tigecycline on adeB gene expression. The antibiotic resistance of the isolates was relatively high.
Also, efflux pump genes, which are the antibiotic resistance factors of A. baumannii, are frequently high in the isolates but it seems that isolates use other effluxe pumps than RND family to exit tigecycline.
Acinetobacter baumannii is an aerobic gram-negative coccobacillus that causes nosocomial pneumonia, bloodstream infections, meningitis, and urinary tract infections (Pan et al. 2016). The prevalence of multidrug resistance in A. baumannii isolates in Iran has increased from 50% in 2001 to 2007 to 74% in 2010 to 2015 (Bialvaei et al. 2017). Patients in the intensive care unit (ICU), and dependent ventilator in particular, are at potential risk of this infection. The high mortality rate accounted for patients with weakened immune systems in ICU. The treatment of A. baumannii infection is greatly difficult due to the high epidemic potential, formation of a biofilm in the external body sites, and multi-drug resistance (MDR) (Liu et al. 2016). Various studies have reported that A. baumannii clinical isolates are resistant to antimicrobial agents such as Aminopenicillins, Uridopenicillins, broad-spectrum Cephalosporins, most Aminoglycosides, Quinolines, chloramphenicol, and Chloramphenicol (Antunes et al. 2014; Towner 2009).
The underlying molecular mechanisms for multiple drug-resistant (MDR) of A. baumannii are related to the changes in membrane permeability and antibiotic target proteins, as well as the production of β-lactamase enzymes, and multidrug efflux pumps(Wang et al. 2014). Efflux pumps play a role in endogenous and acquired resistance in A. baumannii to a variety of antibiotics and antiseptics. Bacterial efflux systems reduce the intra-accumulation of antibiotics leading to the increase of minimum inhibitory concentration (MIC) (Liu et al. 2018). The efflux system of A. baumannii includes resistance nodulation division superfamily (RND), and multidrug and compound extrusion family (MATE) (Coyne et al. 2011). RND pumps such as Acinetobacter drug efflux (Ade) adeB, adeG, adeJ efflux antibiotics, biocides and antiseptic substances via ATP (Abadi et al. 2018) (Xu et al. 2019). Efflux pumps adeB, adeG, adeJ have been reported in Acinetobacter species (Kaviani et al. 2020). In addition, MATE pump, like abeM, effluxs Fluoroquinolones and Imipenem using sodium ion gradient (Xu et al. 2019). In regard to increasing MDR in A. baumannii infection, the use of inhibitors that restore the bacterial sensitivity to antibiotics by inhibiting efflux pumps is needed (Sharma et al. 2019). Efflux pump inhibitors are compounds that block the outpour activity of pumps by competitive and non-competitive methods with substrate. Carbonyl cyanide 3-chlorophenylhydrazone (CCCP) degrades the electrochemical gradient of proton membrane ions by separating phosphorylation from oxidation. This compound can suppress the function of efflux pumps in A. baumannii through disturbing the proton-motive force and may reduce the level of MDR (Moazzen et al. 2018).
The aim of this study was to determine the frequency of efflux pump adeB, adeG, adeJ and abeM genes, and evaluation of the antibiotic effect of Tigecycline on the expression of adeB gene in isolates of A. baumannii, which were resistant to multiple drugs.
Materials and methods
Samples were obtained from patients hospitalized in the ICU Unit of Kashani Hospital, Shahrekord, Iran over a period of 6 months from 2019. All the clinical samples were obtained during the routine procedure of medical care.
Patients and inclusion criteria
We collected 70 isolates from the respiratory secretions of patients. All isolates were transferred to the Cellular and Molecular Research Center. Biochemical tests of fermentation and H2S on triple sugar iron (TSI) agar medium, motility and indole on SIM medium, growing on MacConkey agar medium at 37 and 42, and oxidase/catalase tests were carried out to identify A. baumannii isolates. To confirm A. baumannii species, blaOXA-51 gene was detected (by primer sequences: F: 5′-TAA TGC TTT GAT CGG CCT TG-3′; R: 5′-TGG ATT GCA CTT CAT CTT GG-3′) in isolates. Immune disease background and prior hormone therapy were recognized as the exclusion criterion.
Genomic DNA extraction and PCR
To extract DNA, several colonies of the desired isolates were firstly dissolved in 100 μL of sterile distilled water in the 1.5 mL microtubes. Then, the microtubes were placed in a hot plate (95 °C) for 15 min, and centrifuged for 10 min at 14,000 rpm. The supernatant containing DNA was transferred to a 0.5 mL microtube for PCR reaction. To determine the purity of the extracted DNA, absorption at 260/280 nm was the ratio between 1.8 and 2.
The PCR was performed for adeB, adeG, adeJ and abeM genes using the specific primers (Table.1). The PCR program included a denaturation step for 5 min at 95 °C, with 30 denaturation cycles for 45 s at 95 °C, annealing for 60 s at 58 °C, and extension for 60 s at 72 °C, with a final extension for 5 min at 72 °C. The products from the PCR were electrophoresed in the 1% agarose gel.
Determination of the minimum inhibitory concentration
The minimum inhibitory concentrations (MICs) of three antibiotics including Ciprofloxacin, Trimethoprim-sulfamethoxazole, and Tigecycline for A. baumannii were determined by the broth microdilution method according to the Clinical and Laboratory Standards Institute (CLSI) (Kaviani et al. 2020). Positive control wells included culture medium and bacterial suspension, and negative control wells included culture medium and antibiotics. Pseudomonas aeruginosa ATCC 27853 standard strain was used as the positive control.
To detect isolates containing efflux pumps, 0.25 µg/mL Carbonyl cyanide 3-chlorophenylhydrazone (CCCP) was added to broth medium in the separate micro plate, and MIC was evaluated. Finally, by comparing the MICs before and after adding CCCP efflux pump inhibitor, the isolates with titer reduction were considered as isolates with efflux pump.
RNA isolation and RT-PCR
To examine adeB gene expression, isolated were treated with MIC and sub MIC of CCCP. RNA from each isolate was extracted using RNX- Plus reagent (SinaClon BioScience; Iran) solution according to the manufacturer’s instructions. The Thermo Scientific™ NanoDrop 2000 calculated the concentration and purification of each RNA sample. cDNAs were synthesized using the Revert Aid first-strand cDNA synthesis kit (Yektatajhiz; Iran) with 1.5 μg of RNA at a 20 μL reaction rate. The Real-Time PCR was conducted on a Rotor-Gene RG-300 (Corbett Research, Sydney, AU) and SYBR Green Real-time PCR Master Mix kit (Yektatajhiz; Iran) to show the quantification of mRNA. A paired primer was applied for the amplification of adeB gene (primer sequence: F: 5'-AACGGACGACCATCTTTGAG-3'; R: 5'-CAGTTGTTCCATTTCACGCA-3'). Thermal cycling continued the denaturation process at 95 °C for 5 min for the first denaturation stage at 95 °C for 5 min and then 38 cycles at 95 °C for 15 s, 61 °C for 20 and 72 for 25 s. The amplification specificity of adeB gene expression was confirmed by the melting curve. adeB gene expression was standardized against 16sRNA as an internal control, and relative quantification (2−ΔΔCq) revealed the fold changes of expression.
All the data analyzed in this study were anonymized. The mean ± standard deviation was viewed as results. Comparisons between positive and negative genes and abeM gene expression were calculated using t-tests and χ2tests. Drug resistance was assessed by logistic regression for analyzing the odds ratio after adjustment for gender, mean age. Differences were found statistically meaningful for P-values less than 0.05. The data were analyzed using SPSS version 24.
Specimen collection and culture
In this study, there were 56 men and 14 women with mean age of 58.16 years. All 70 isolates were identified as A. baumannii by biochemical differential tests. Also, blaOXA-51 gene PCR confirmed the isolation of A. baumannii.
Pattern of antibiotic resistance
MIC microdilution method was used to determine antibiotic resistance, and Ciprofloxacin, Trimethoprim-sulfamethoxazole, and Tigecycline antibiotics were evaluated in this study. As can be observed in Table.2, the antibiotic resistance rate for Ciprofloxacin (S ≤ 1, I = 2, R ≥ 4 µg/mL), Trimethoprim-sulfamethoxazole (S ≤ 2/38, R ≥ 74.4 µg/mL), and Tigecycline (S ≤ 1, R ≥ 2 µg/mL) were measured according to the US CLSI criteria. The results showed that the highest antibiotic resistance accounted for Ciprofloxacin, and Trimethoprim-sulfamethoxazole, and Tigecycline were in the next level of antibiotic resistance respectively.
The results of the antibiotic resistance test by the MIC method indicated that 50 isolates contained A. baumannii with efflux pump (Table 3).
PCR results for adeB, adeG, adeJ and abeM genes
After identifying isolates with efflux pump (50 isolates), the frequency of adeB, adeG, adeJ and abeM genes was examined by PCR on these isolates. The results showed that the frequency of adeB, adeG, adeJ and abeM genes in A. baumannii isolates were 100%, 90%, 86%, and 98% respectively.
The effect of Tigecycline antibiotic on adeB gene expression
The effect of Tigecycline on adeB gene expression was evaluated using Real-Time PCR in A. baumannii isolates at MIC concentrations. The resulst showed that CCCP resulted in the reduction of adeB gene expression that difference at the doses of MIC was significant compared to the control group (Fig. 1).
A. baumannii is a gram-negative, aerobic, non-fermentative and oxidase-negative coccobacillus. This opportunistic bacterium is one of the most important causative agents of nosocomial infections that can be isolated from blood, sputum, pleural fluid and urine samples of patients. A. baumannii is involved in nosocomial infections such as endocarditis, meningitis, pneumonia, burns and sepsis (Bergogne-Bérézin and Towner 1996). One of the unique features of A. baumannii is resistance to antibiotics and acquiring resistance genes to antibiotics, which exacerbate the treatment in patients with the deficient immune system. Recently, A. baumannii strains with the resistant ability to all common antibiotic classes are undergone prevalence in healthcare systems (Moammadi et al. 2014). ICU accounts for only about 5–15% of hospital beds, but more than 30% of nosocomial infections are related to these sections. A. baumannii is resistant to most antibiotics, such as aminoglycosides, fluoroquinolones, beta-lactams, and cephalosporins, presenting more challenges for treatment (Amini et al. 2016).
In this study, 70 isolates of A. baumannii were collected from the pulmonary secretions of patients admitted to the ICU of Kashani Hospital of Shahrekord. We investigated the pattern of antibiotic resistance of these isolates against the Ciprofloxacin, Trimethoprim-sulfamethoxazole, and Tigecycline antibiotics. The resistance to Ciprofloxacin, Trimethoprim-sulfamethoxazole, and Tigecycline antibiotics in this study were 97.1%, 95.8% and 37.3% respectively. A meta-analysis study carried out in 2017 indicated 87 ± 12 antibiotic resistance rate to Ciprofloxacin in 11 hospitals (Hidron et al. 2008). Afshari et al. examined the pattern of antibiotic resistance for A. baumannii isolates from patients referred to the ICU section. The resistance of the isolates to Ciprofloxacin was 94% and the resistance to Tigecycline was 92% (Yavari et al. 2016). In 2017, Kia et al. evaluated the frequency of antibiotic resistance of A. baumannii in clinical isolates from respiratory secretions, urine, blood and body fluids of patients in ICU, surgical, infectious, orthopedic and burn sections in Kerman. In this study, the resistance to Ciprofloxacin and Tigecycline was reported to be 98% and 36% respectively (Emami et al. 2018).
The activation of efflux pumps has been proposed as an intrinsic mechanisms of antibiotic resistance in bacteria (Vila et al. 2007). The frequency of adeB, adeG, adeJ genes from RND family and abeM gene from MATE family were analyzed by PCR. RND and MATE families are classified as the efflux pumps in A. baumannii that maximize the concentration of MIC. RND family efflux pumps play a crucial role in the development of antibiotic resistance in A. baumannii. Three types of RND family, including AdeABC, AdeIJK, and AdeFGH efflux pumps, have been identified (Magnet et al. 2001). The frequency of adeB, adeG adeJ and abeM in our study were 100%, 90%, 86% and 98%, respectively. In 2019, the prevalence of efflux pump genes was examined among 154 isolates of A. baumannii in Korea. The frequency of adeG, adeB, adeE, adeY, abeM and adej genes were 98.7%, 89%, 13.6%, 7.7%, 95.5% and 98.9% respectively (Choi et al. 2019). In a similar investigation, the frequency of adeA, adeB, adeC, AbeM, and adeS genes in isolates of multidrug-resistant A. baumannii isolated from patients admitted to Alzahra Hospital in Isfahan was evaluated as 100%, 96%, 95%, and 8, respectively. From 80 A. baumannii isolates of this study, 39 isolates had a MIC higher than 32 μL and were resistant to Amikacin, 41 isolates with a MIC greater than 2 μL. Following the combination of CCCP inhibitor, 25 isolates had a twofold decrease and 15 isolates had a fourfold decrease in the MIC of Amikacin (Ostadi et al. 2019). The difference in the frequency of genes in various studies is in consist with geography and epidemiology of these areas. However, the results of the frequency of efflux pump genes in the present study are similar to most studies, and indicate the high frequency of efflux pump genes in A. baumannii isolates from pulmonary secretions.
Additionally, CCCP inhibitor was used to identify efflux pumps in A. baumannii isolates. After using CCCP, the MIC changes of the isolates were 64.3% for Ciprofloxacin, 51.5% for Trimethoprim-sulfamethoxazole and 50% for Tigecycline. The CCCP compound with inhibitory capacity of cytochrome oxidase blocks the electron transfer chain at position 3. Interruption of the electron transfer chain causes phosphorylation to separate from oxidation and destroys the electrochemical gradient of proton ions in the membrane (JaponiNejad 2014). Thus, the CCCP can inhibit efflux pumps, including efflux pumps of A. baumannii species, which use proton-driven force to remove antimicrobials from the cell and reduce the level of drug resistance in bacteria (Piddock and Johnson 2002). Studies have shown that efflux pumps increase the MIC of the antibiotics Ofloxacin, Ciprofloxacin and Gentamicin in A. baumannii (Basatian-Tashkan et al. 2020). A study by Hornsey et al. in 2010 demonstrated a rise in the MIC of Tigecycline by increasing the expression of adeABC efflux pumps (Patel et al. 2010). In the results of Ardabili et al., all strains of A. baumannii were resistant to Ciprofloxacin, at about 4–128 µg/mL, in MIC measurement. Likewise, they showed that the resistance of the strains to Ciprofloxacin decreased 2–64-fold in the presence of the CCCP efflux pump inhibitor in 86% of the strains (Mahamoud et al. 2007). In 2006, a significant reduction in the MIC of antibiotic-resistant strains using the CCCP inhibitor was reported. The observations of this study also indicated that drug resistance in clinical isolates was mediated by an active efflux pump that transports the accumulated drug to the outside (Abdi-Ali et al. 2006). Beheshti et al. have reported the role of efflux pumps in the resistance of A. baumannii isolates to Tetracycline antibiotics. In this study, by adding CCCP inhibitor, a decrease in MIC in tetracycline-resistant A. baumannii isolates was observed, which decreased 2–4 folds in 18 isolates, 8 folds in 26 isolates, 16 folds in 1 isolate, and 32 folds in 1 isolate (Beheshti et al. 2014). Comparison of the results of the present study with other studies shows that efflux pumps have been effective in the development of antibiotic resistance in A. baumannii isolates. The difference between the results of isolates with an effusion pump in this study and the results of other studies is due to the diversity of samples used in those studies compared to the present study.
Furthermore, the effect of Tigecycline on the expression of adeB gene was examined in the isolates containing abeM gene. The relationship between increased adeB gene expression and its association with increased resistance to Tigecycline in A. baumannii has been reported in Yang et al.’s study (Yang et al. 2019). 61% of isolates with antibiotic resistance in a study in Egypt were prone to a significant increase of adeB gene expression compared to sensitive isolates (Aladel et al. 2020). Ardehali et al. in their study found the association between adeJ gene expression and its association with increased resistance to Tigecycline in A. baumannii (Ardehali et al. 2019). Although an increase in the expression of adeB gene has been reported in antibiotic resistance A. baumannii isolates, the expression of adeB gene in our study showed a decrease in the presence of the antibiotic Tigecycline. In regard to the various mechanisms of antibiotic resistance, the development of antibiotic resistance of A. baumannii isolates should also be considered. On the other hand, it is possible that the bacterium expressed other genes in the RND family when exposed to antibiotic treatment. It should also be noted that the mere expression of efflux pump genes in isolates does cause resistance. The expression of RND family genes is controlled by other regulatory genes. Any mutation in these regulatory genes affects the expression of genes under their control. According to the results of this study and previous studies, various strains of A. baumannii seem to use efflux pump for antibiotics resistance.
Antibiotic resistance among A. baumannii isolates can make efforts to introduce inhibitors of efflux pumps along with antibiotics in order to inactivate the activity of efflux pumps and prevent the development of antibiotic resistance. Based on the Real time PCR results it seems that isolates use other effluxe pumps than RND family to exit tigecycline. It is also suggested that due to the frequency of efflux pumps in the studied isolates, the expression of other genes of RND family such as adeG and adeJ genes of efflux pump as well as abeM gene of MATE family which are pumps in A. baumannii should be studied in future studies.
Availability of data and materials
The data are available. All data generated or analyzed during this study are included in this study.
Minimum inhibitory concentration
Carbonyl cyanide m-chlorophenyl hydrazone inhibitor
Intensive care unit
Resistance nodulation division superfamily
Multidrug and compound extrusion family
Acinetobacter drug efflux
Triple sugar iron
Polymerase chain reaction
Abadi MSS, Gholipour A, Hadi N (2018) The highly conserved domain of RND multidrug efflux pumps in pathogenic Gram-negative bacteria. Cell Mol Biol 64:79–83
Abdi-Ali A, Mohammadi-Mehr M, Agha Alaei Y (2006) Bactericidal activity of various antibiotics against biofilm-producing Pseudomonas aeruginosa. Int J Antimicrob Agents 27(3):196–200
Afshar Yavari S, Rota S, Caglar K, Fidan I (2016) Determination of resistance pattern of isolated Acintobacter baumannii from intensive care units (ICUS) in Gazi Hospital, Ankara. Nurs Midwifery J 13(10):912–928
Aladel R, Abdalsameea S, Badwy H, Refat S, ElKholy R (2020) Role of AdeB gene in multidrug-resistance Acinetobacter. Menoufia Med J Medknow 33(1):205
Amini N, Amini N, Rezaei K, Yazdannik A (2016) Effect of nebulized eucalyptus on contamination of microbial plaque of endotracheal tube in ventilated patients. Iran J Nurs Midwifery Res 21(2):165–170
Antunes LCS, Visca P, Towner KJ (2014) n o Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis 71:292–301
Ardehali SH, Azimi T, Fallah F, Owrang M, Aghamohammadi N, Azimi L (2019) Role of efflux pumps in reduced susceptibility to tigecycline in Acinetobacter baumannii. New Microbes New Infect 30:100547
Basatian-Tashkan B, Niakan M, Khaledi M, Afkhami H, Sameni F, Bakhti S (2020) Antibiotic resistance assessment of Acinetobacter baumannii isolates from Tehran hospitals due to the presence of efflux pumps encoding genes (adeA and adeS genes) by molecular method. BMC Res Notes 13(1):543
Beheshti M, Talebi M, Ardebili A, Bahador A, Lari A (2014) Detection of AdeABC efflux pump genes in tetracycline-resistant Acinetobacter baumannii isolates from burn and ventilator-associated pneumonia patients. J Pharm Bioall Sci 6(4):229–32
Bergogne-Bérézin E, Towner KJ (1996) Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 9:148–65
Bialvaei AZ, Kouhsari E, Salehi-Abargouei A, Amirmozafari N, Ramazanzadeh R, Ghadimi-Daresajini A (2017) Epidemiology of multidrug-resistant Acinetobacter baumannii strains in Iran: a systematic review and meta-analysis. J Chemother 29:327–37
Choi I-S, Choi JA, Jang SJ, Park G, Jeong SH, Kim C-M (2019) Distribution of adeG, adeB, adeE, adeY, abeM, and adeJ efflux pump genes in clinical isolates of Acinetobacter species from Korea. Lab Med Online 9(4):201
Coyne S, Courvalin P, Périchon B (2011) Efflux-mediated antibiotic resistance in Acinetobacter spp Antimicrob agents chemother. Antimicrob Agents Chemother 55(947):53
Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA (2008) Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2006–2007. Infect Control Hosp Epidemiol 29(11):996–1011
JaponiNejad AR (2014) Molecular detection of AdeABC efflux pump genes in clinical isolates of Acinetobacter baumannii and their contribution in imipenem resistance. ISMJ 17(5):815–823
Kaviani R, Pouladi I, Niakan M, Mirnejad R (2020) Molecular detection of adefg efflux pump genes and their contribution to antibiotic resistance in Acinetobacter baumannii clinical isolates. Rep Biochem Mol Biol 8(4):413–8
Liu H, Wu YQ, Chen LP, Gao X, Huang HN, Qiu FL (2016) Biofilm-related genes: analyses in multi-antibiotic resistant Acinetobacter baumannii isolates from mainland China. Med Sci Monit 22:1801–1807
Liu Q, Hassan KA, Ashwood HE, Gamage HKAH, Li L, Mabbutt BC (2018) Regulation of the aceI multidrug efflux pump gene in Acinetobacter baumannii. J Antimicrob Chemother 73(6):1492–500
Magnet S, Courvalin P, Lambert T (2001) Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob Agents Chemother 45(12):3375–80
Mahamoud A, Chevalier J, Alibert-Franco S, Kern WV, Pagès JM (2007) Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy. J Antimicrob Chemother 59:1223–9
Moammadi F, Arabestani MR, Safari M, Roshanaii G, Alikhani MY (2014) Prevalence of class1, 2 and 3 integrons among extensive drug resistance Acinetobacter baumanii strains isolated from intensive care units in Hamadan, west province. Iran Iran J Med Microbiol 8:8–14
Moazzen Z, Eslami G, Hashemi A, Nojookambari NY (2018) Efflux pump inhibitor carbonyl cyanide 3-chlorophenylhydrazone (CCCP) effect on the minimum inhibitory concentration of ciprofloxacin in Acinetobacter baumannii strains. Arch Clin Infect Dis. https://doi.org/10.5812/archcid.59644
Ostadi Y, Rezai AA, Moghadampour M, Faghri J (2019) The involvement of drug efflux system in amikacin resistance of multiple drug resistant Acintobacter baumannii isolates in Isfahan, Iran. J Med Bacteriol 8:13–20
Pan T, Liu X, Xiang S, Ji W (2016) Treatment for patients with multidrug resistant Acinetobacter baumannii pulmonary infection. Exp Ther Med 11(4):1345–7
Patel D, Kosmidis C, Seo SM, Kaatz GW (2010) Ethidium bromide MIC screening for enhanced efflux pump gene expression or efflux activity in Staphylococcus aureus. Antimicrob Agents Chemother 54(12):5070–3
Piddock LJV, Johnson MM (2002) Accumulation of 10 fluoroquinolones by wild-type or efflux mutant Streptococcus pneumoniae. Antimicrob Agents Chemother 46(3):813–20
Sharma A, Gupta VK, Pathania R (2019) Efflux pump inhibitors for bacterial pathogens: from bench to bedside. Indian J Med Res 2:129–45
Towner KJ (2009) Acinetobacter: an old friend, but a new enemy. J Hosp Infect 4:355–63
Vahidi Emami H, Khalilian M, Yadollahi MN (2018) Antibiotic resistance patterns and prevalence of PER and VEB resistance genes among clinical isolates of ESBL-producing Acinetobacter baumannii. Med Lab J 12(1):21–6
Vila J, Martí S, Sánchez-Céspedes J (2007) Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother 59:1210–5
Wang N, Ozer EA, Mandel MJ, Hauser AR (2014) Genome-wide identification of Acinetobacter baumannii genes necessary for persistence in the lung. MBio 5(3):1–8
Xu C, Bilya SR, Xu W (2019) adeABC efflux gene in Acinetobacter baumannii. New Microbes New Infect 30:100549
Yang YS, Chen HY, Hsu WJ, Chou YC, Perng CL, Shang HS (2019) Overexpression of AdeABC efflux pump associated with tigecycline resistance in clinical Acinetobacter nosocomialis isolates. Clin Microbiol 25(4):512.e1-512.e6
This study was funded by Shahrekord University of Medical Sciences (Grant Number 2389).
Ethics approval and consent to participate
This study was approved by Shahrekord University of Medical Sciences Ethics Committee (with the number: IR.SKUMS.REC1399.057).
Consent for publication
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Rafiei, E., Shahini Shams Abadi, M., Zamanzad, B. et al. The frequency of efflux pump genes expression in Acinetobacter baumannii isolates from pulmonary secretions. AMB Expr 12, 103 (2022). https://doi.org/10.1186/s13568-022-01444-4
- Antibiotic resistance
- Efflux Pump